Andrada Mining acquisition elevates the miner to emerging mid-tier status. Watch the video here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksAstrazeneca Share News (AZN)

Share Price Information for Astrazeneca (AZN)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 12,356.00
Bid: 12,390.00
Ask: 12,394.00
Change: 28.00 (0.23%)
Spread: 4.00 (0.032%)
Open: 12,364.00
High: 12,454.00
Low: 12,322.00
Prev. Close: 12,328.00
AZN Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Earnings, Trading Statements Calendar - Week Ahead

Thu, 23rd Jul 2015 15:14

UK Earnings, Trading Statements Calendar 
Friday, July 24 
Anglo AmericanHalf Year Results
BeazleyHalf Year Results
HammersonHalf Year Results
PearsonHalf Year Results
Volex GroupQ1 Interim Management Statement
Close BrothersTrading Update
Helical BarInterim Management Statement
LonminQ3 Interim Management Statement/Production Report
Vodafone GroupQ1 Interim Management Statement
AG BarrTrading Update
Monday, July 27 
DialightHalf Year Results
Reckitt BenckiserHalf Year Results
HiscoxHalf Year Results
Acacia MiningHalf Year Results
GoodwinFull Year Results
CranswickQ1 Interim Management Statement
XP PowerHalf Year Results
SeniorHalf Year Results
Fevertree DrinksHalf Year Results
Nakama GroupFull Year Results
Tuesday, July 28 
BPHalf Year Results
GKNHalf Year Results
NextQ2 Trading Statement
GreencoreInterim Management Statement
Provident Financial GroupHalf Year Results
McColl's RetailHalf Year Results
ShawbrookHalf Year Results
Virgin MoneyHalf Year Results
SEGROHalf Year Results
Tullett PrebonHalf Year Results
Rathbone BrothersHalf Year Results
InformaHalf Year Results
Domino's Pizza GroupHalf Year Results
ITVHalf Year Results
Jardine Lloyd ThompsonHalf Year Results
International Game TechnologyHalf Year Results
PaceHalf Year Results
Greencoat UK WindHalf Year Results
Burford CapitalHalf Year Results
Games Workshop Half Year Results
DraxHalf Year Results
ElementisHalf Year Results
CarpetrightHalf Year Results
Wednesday, July 29 
Brewin DolphinInterim Management Statement
Capital Counties & PropertiesHalf Year Results
AntofagastaQ2 Production Report
Compass GroupInterim Management Statement
DignityHalf Year Results
DiplomaQ3 Results
BarclaysHalf Year Results
British American TobaccoHalf Year Results
GlaxoSmithKlineQ2 Results
4imprintHalf Year Results
Jupiter Fund ManagementHalf Year Results
Lancashire HoldingsQ2 Resiults
RightmoveHalf Year Results
International Personal FinanceHalf Year Results
FoxtonsHalf Year Results
Pets At HomeTrading Update
Polymetal InternationalQ2 Production Report
TSB Banking GroupHalf Year Results
RenishawHalf Year Results
Tate & LyleInterim Management Statement
Tarsus GroupHalf Year Results
CapitaHalf Year Results
Taylor WimpeyHalf Year Results
Riverstone EnergyHalf Year Results
Stanley GibbonsTrading Update
Paragon GroupQ3 Interim Management Statement 
Aberforth Smaller Cos TrustHalf Year Results
SkyFull Year Results
JKX Oil & Gas Half Year Results
Circassia PharmaceuticalsHalf Year Results
St James's PlaceHalf Year Results
TymanHalf Year Results
WS AtkinsHalf Year Results
Law DebentureHalf Year Results
Mithras Investment TrustHalf Year Results
National ExpressHalf Year Results
Tullow OilHalf Year Results
Man GroupHalf Year Results
Telecity Half Year Results
Essar EnergyQ1 Results
FDM GroupHalf Year Results
IndiviorHalf Year Results
Mitchells & ButlersQ3 Interim Management Statement 
Thursday, July 30 
AstraZenecaHalf Year Results
Royal Dutch ShellHalf Year Results
CentricaHalf Year Results
Intercontinental Hotels GroupHalf Year Results
Halfords GroupQ1 Interim Management Statement 
InchcapeHalf Year Results
Moneysupermarket.comHalf Year Results
Hemderson GroupHalf Year Results
LairdHalf Year Results
Millennium & Copthorne HotelsHalf Year Results
SpectrisHalf Year Results
SchrodersHalf Year Results
BAE SystemsHalf Year Results
Rolls Royce HoldingsHalf Year Results
Royal Bank of Scotland GroupHalf Year Results
Babcock InternationalTrading Update
Smith & NephewHalf Year Results
CountrywideHalf Year Results
3i GroupInterim Management Statement
VictoriaFull Year Results
BodycoteHalf Year Results
BT GroupHalf Year Results
Centaur MediaHalf Year Results
CommunisisHalf Year Results
DiageoHalf Year Results
Intu PropertiesHalf Year Results
KAZ MineralsQ2 Production Report
Management Consulting Group Half Year Results
Merlin EntertainmentsHalf Year Results
RPS GroupHalf Year Results
Thomas CookQ3 Interim Management Statement 
Weir GroupHalf Year Results
XchangingHalf Year Results
Rentokil InitialHalf Year Results
RexamHalf Year Results
Robert WaltersHalf Year Results
  
Copyright 2015 Alliance News Limited. All Rights Reserved.

More News
16 Oct 2023 08:34

TOP NEWS: AstraZeneca's cancer drug gets priority review from US FDA

(Alliance News) - AstraZeneca PLC on Monday said that its new drug application for Tagrisso has been granted priority review in the US, after trial results extended progression-free survival.

Read more
4 Oct 2023 12:14

IN BRIEF: AstraZeneca's Forxiga drug shows positive results in trial

AstraZeneca PLC - Cambridge-based pharmaceutical maker - Says Forxiga drug meets primary endpoints in T2NOW phase three trial and shows "clinically meaningful" improvements in the glycaemic control among type two diabetes patients between the ages of 10 and 17. Adds safety results in patient cohort were consistent with those in adults with type two diabetes.

Read more
3 Oct 2023 16:55

LONDON MARKET CLOSE: Stocks red as rate rise fears continue to grow

(Alliance News) - Stocks in London were lower at the close on Tuesday after unexpectedly strong US job openings data added to fears that interest rates in the world's largest economy will stay higher for longer.

Read more
3 Oct 2023 11:59

LONDON MARKET MIDDAY: HSBC and StanChart help FTSE 100 outperform

(Alliance News) - London's FTSE 100 grew in confidence as Tuesday morning progressed, going into the afternoon in the green and outperforming European peers.

Read more
3 Oct 2023 08:36

TOP NEWS: AstraZeneca settles Nexium and Prilosec litigation

(Alliance News) - AstraZeneca PLC on Tuesday said it has settled legal matters involving its Nexium acid reflux and Prilosec heartburn products, parting with USD425 million.

Read more
3 Oct 2023 07:41

LONDON BRIEFING: Greggs sales rise; boohoo cuts revenue outlook

(Alliance News) - London's FTSE 100 is set to fall further on Tuesday, after a sell-off at the start of the week, with hawkish words from a US central banker reinforcing the 'higher-for-longer' interest rates messaging.

Read more
3 Oct 2023 07:24

AstraZeneca agrees to settle most Nexium, Prilosec claims

(Sharecast News) - Global pharmaceutical company AstraZeneca has agreed to settle litigation on product liability related to two of its widely-used heartburn drugs, Nexium and Prilosec, it announced on Tuesday.

Read more
25 Sep 2023 09:13

LONDON BROKER RATINGS: Jefferies raises AstraZeneca to 'buy'

(Alliance News) - The following London-listed shares received analyst recommendations Monday morning:

Read more
25 Sep 2023 07:43

LONDON BRIEFING: Stocks seen lower; Aviva buys AIG's UK protection arm

(Alliance News) - Stocks in London were set to open lower on Monday as investors eyed fresh concerns for the already fragile Chinese property sector.

Read more
22 Sep 2023 08:42

LONDON MARKET OPEN: Stocks slip after central bank rate calls

(Alliance News) - Stock prices in London opened lower on Friday, but managed to avoid the steep declines seen in New York, as investors mulled over an eventful week dominated by central bank decisions.

Read more
22 Sep 2023 08:13

TOP NEWS: AstraZeneca's datopotamab deruxtecan shows positive results

(Alliance News) - AstraZeneca PLC on Friday said phase three data showed that datopotamab deruxtecan delivered improvement in progression-free survival in breast cancer patients.

Read more
22 Sep 2023 07:27

AstraZeneca reports positive findings from breast cancer threatment trial

(Sharecast News) - New high-level results from AstraZeneca's TROPION-Breast01 phase three trial, released on Friday, carried encouraging news for patients with inoperable or metastatic hormone receptor (HR)-positive, HER2-low or negative breast cancer.

Read more
20 Sep 2023 08:44

TOP NEWS: AstraZeneca's rare disease business buys Pfizer portfolio

(Alliance News) - AstraZeneca PLC on Wednesday said rare disease business Alexion has signed a purchase and licence agreement for a rare disease programme portfolio from Pfizer Inc.

Read more
15 Sep 2023 15:27

AstraZeneca and Daiichi Sankyo's Enhertu recommended for approval

(Alliance News) - AstraZeneca PLC and Daiichi Sankyo Co Ltd's Enhertu has been recommended for approval in the EU on Friday.

Read more
14 Sep 2023 08:25

Smith & Nephew brings BT Chief Financial Officer Simon Lowth to board

(Alliance News) - Smith & Nephew PLC on Thursday announced that BT Group PLC's chief financial officer, Simon Lowth, will join the board as independent non-executive director on January 1.

Read more

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.